Viracept (nelfinavir) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat human immunodeficiency virus type 1 (HIV-1) infection in adults and children ages 2 and older.
Viracept is a type of HIV medicine called a protease inhibitor. It blocks HIV-1 protease, an enzyme the virus needs to make new virus particles that can infect other cells.
Doctors prescribe Viracept when treating HIV-1 in adults and children ages 2 and older, in combination with other antiretroviral medicines.
HIV-1 is the virus that causes acquired immune deficiency syndrome (AIDS).
Viracept comes as tablets and an oral powder. It should be taken with a meal.
If you or your child cannot swallow Viracept tablets, the tablets may be dissolved in a small amount of water. Mix the cloudy liquid well and drink it right away. Rinse the glass with water and drink the rinse to make sure the full dose is taken.
Viracept oral powder may be mixed with a small amount of water, milk, formula, soy formula, soy milk, or a dietary supplement. The entire mixture should be taken to make sure the full dose is received. If the mixture is not taken right away, it should be refrigerated and used within six hours.
Do not mix Viracept oral powder with acidic foods or juices, such as orange juice, apple juice, or applesauce, because the mixture may taste bitter. Do not mix the powder with water in its original container.
For adults and adolescents ages 13 and older, the recommended dose is either:
For children ages 2 to 12, the dose is based on body weight. The healthcare provider will choose the right dose and form of Viracept.
For twice-daily dosing, the recommended amount is 45 to 55 milligrams per kilogram per dose:
For dosing three times daily, the recommended amount is 25 to 35 milligrams per kilogram per dose:
Children may take 250-milligram tablets or Viracept oral powder. The healthcare provider should tell the caregiver exactly how much powder to give based on the child’s weight.
This information is based on prescribing information, but your healthcare provider may tailor your treatment plan. Always follow their guidance.
In clinical studies of Viracept, the following side effects occurred in about 1 percent to 20 percent of adults and adolescents, depending on the study and treatment group.
Common side effects in adults and adolescents include:
Common side effects in children include:
Viracept can cause serious side effects that may require immediate medical attention. These include:
Get medical help right away if you think you are having a serious reaction.
Before starting Viracept, tell your doctor if you have any allergies to nelfinavir or any ingredients in Viracept.
Tell your doctor about all medicines you take, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements.
Also tell your doctor if you:
Do not take Viracept with:
Do not miss doses or let your supply of Viracept run out. The amount of virus in your blood may increase, and the virus may become harder to treat.
If you miss a dose, take it as soon as possible and then return to your regular schedule. If you skip a dose, do not take two doses at the same time.
If you are pregnant or become pregnant while taking Viracept, tell your healthcare provider. Because liver-related problems have been reported during pregnancy and Viracept levels may be lower later in pregnancy, your healthcare provider may consider another HIV medicine.
A pregnancy registry tracks pregnancy outcomes in people exposed to Viracept. Healthcare providers can register pregnancies through the Antiretroviral Pregnancy Registry or by calling 800-258-4263.
Viracept may make some estrogen-based birth control pills less effective. Use an alternative or additional form of birth control as advised by your healthcare provider.
Do not breastfeed while taking Viracept. HIV-1 can pass to a baby through breast milk, and nelfinavir can also pass into breast milk.
These answers are fact-checked by our editorial staff.
How effective is Viracept for HIV?
Viracept was studied as part of combination HIV treatment.
In one adult study, 61 percent of people taking Viracept 1,250 milligrams twice daily with stavudine and lamivudine had HIV RNA below 400 copies per milliliter at week 48. This was compared with 58 percent of people taking Viracept 750 milligrams three times daily with the same two medicines.
In a study of treatment-experienced children, 42 percent of children taking stavudine, lamivudine, and Viracept had HIV RNA below 400 copies per milliliter at week 48.
Can Viracept be used with other medicines for HIV?
Yes. Viracept is meant to be used with other HIV medicines, called antiretroviral medicines, to treat HIV-1 infection. Your healthcare provider will choose the combination that is right for you.
Can Viracept interact with other HIV medicines?
Yes. Viracept can interact with some HIV medicines:
For several of these combinations, safe and effective doses have not been established. Tell your healthcare provider about all HIV medicines you take so they can check for interactions.
On myHIVteam, people share their experiences with HIV, get advice, and find support from others who understand.
Learn more about Viracept and HIV care:
More resources from myHIVteam that mention Viracept
Become a member to get even more